These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 18471519)

  • 1. Knockdown of RNA binding protein musashi-1 leads to tumor regression in vivo.
    Sureban SM; May R; George RJ; Dieckgraefe BK; McLeod HL; Ramalingam S; Bishnupuri KS; Natarajan G; Anant S; Houchen CW
    Gastroenterology; 2008 May; 134(5):1448-58. PubMed ID: 18471519
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dual Knockdown of Musashi RNA-Binding Proteins MSI-1 and MSI-2 Attenuates Putative Cancer Stem Cell Characteristics and Therapy Resistance in Ovarian Cancer Cells.
    Löblein MT; Falke I; Eich HT; Greve B; Götte M; Troschel FM
    Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34768932
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Knockdown of Musashi RNA Binding Proteins Decreases Radioresistance but Enhances Cell Motility and Invasion in Triple-Negative Breast Cancer.
    Troschel FM; Minte A; Ismail YM; Kamal A; Abdullah MS; Ahmed SH; Deffner M; Kemper B; Kiesel L; Eich HT; Ibrahim SA; Götte M; Greve B
    Int J Mol Sci; 2020 Mar; 21(6):. PubMed ID: 32245259
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Knockdown of the prognostic cancer stem cell marker Musashi-1 decreases radio-resistance while enhancing apoptosis in hormone receptor-positive breast cancer cells via p21
    Troschel FM; Palenta H; Borrmann K; Heshe K; Hua SH; Yip GW; Kiesel L; Eich HT; Götte M; Greve B
    J Cancer Res Clin Oncol; 2021 Nov; 147(11):3299-3312. PubMed ID: 34291358
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NOB1 is essential for the survival of RKO colorectal cancer cells.
    He XW; Feng T; Yin QL; Jian YW; Liu T
    World J Gastroenterol; 2015 Jan; 21(3):868-77. PubMed ID: 25624720
    [TBL] [Abstract][Full Text] [Related]  

  • 6. C-terminal deletion mutant p21(WAF1/CIP1) enhances E2F-1-mediated apoptosis in colon adenocarcinoma cells.
    Elliott MJ; Stilwell A; Dong YB; Yang HL; Wong SL; Wrightson WR; Martin RC; McMasters KM
    Cancer Gene Ther; 2002 May; 9(5):453-63. PubMed ID: 11961668
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The adult stem cell marker Musashi-1 modulates endometrial carcinoma cell cycle progression and apoptosis via Notch-1 and p21WAF1/CIP1.
    Götte M; Greve B; Kelsch R; Müller-Uthoff H; Weiss K; Kharabi Masouleh B; Sibrowski W; Kiesel L; Buchweitz O
    Int J Cancer; 2011 Oct; 129(8):2042-9. PubMed ID: 21165952
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppression of intestinal tumorigenesis in
    Wolfe AR; Ernlund A; McGuinness W; Lehmann C; Carl K; Balmaceda N; Neufeld KL
    J Cell Sci; 2017 Feb; 130(4):805-813. PubMed ID: 28082422
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of putative stem cell genes Musashi-1 and beta1-integrin in human colorectal adenomas and adenocarcinomas.
    Fan LF; Dong WG; Jiang CQ; Xia D; Liao F; Yu QF
    Int J Colorectal Dis; 2010 Jan; 25(1):17-23. PubMed ID: 19714342
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NOTCH3 signaling regulates MUSASHI-1 expression in metastatic colorectal cancer cells.
    Pastò A; Serafin V; Pilotto G; Lago C; Bellio C; Trusolino L; Bertotti A; Hoey T; Plateroti M; Esposito G; Pinazza M; Agostini M; Nitti D; Amadori A; Indraccolo S
    Cancer Res; 2014 Apr; 74(7):2106-18. PubMed ID: 24525742
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dysregulated Stem Cell Markers Musashi-1 and Musashi-2 are Associated with Therapy Resistance in Inflammatory Breast Cancer.
    Haiduk TS; Sicking M; Brücksken KA; Espinoza-Sánchez NA; Eder KM; Kemper B; Eich HT; Götte M; Greve B; Troschel FM
    Arch Med Res; 2023 Sep; 54(6):102855. PubMed ID: 37481823
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective blockade of DCAMKL-1 results in tumor growth arrest by a Let-7a MicroRNA-dependent mechanism.
    Sureban SM; May R; Ramalingam S; Subramaniam D; Natarajan G; Anant S; Houchen CW
    Gastroenterology; 2009 Aug; 137(2):649-59, 659.e1-2. PubMed ID: 19445940
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activity of a novel bcl-2/bcl-xL-bispecific antisense oligonucleotide against tumors of diverse histologic origins.
    Gautschi O; Tschopp S; Olie RA; Leech SH; Simões-Wüst AP; Ziegler A; Baumann B; Odermatt B; Hall J; Stahel RA; Zangemeister-Wittke U
    J Natl Cancer Inst; 2001 Mar; 93(6):463-71. PubMed ID: 11259472
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Knockdown of RPL9 expression inhibits colorectal carcinoma growth via the inactivation of Id-1/NF-κB signaling axis.
    Baik IH; Jo GH; Seo D; Ko MJ; Cho CH; Lee MG; Lee YH
    Int J Oncol; 2016 Nov; 49(5):1953-1962. PubMed ID: 27633352
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Translation inhibition during cell cycle arrest and apoptosis: Mcl-1 is a novel target for RNA binding protein CUGBP2.
    Subramaniam D; Natarajan G; Ramalingam S; Ramachandran I; May R; Queimado L; Houchen CW; Anant S
    Am J Physiol Gastrointest Liver Physiol; 2008 Apr; 294(4):G1025-32. PubMed ID: 18292181
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loss of p21Waf1/Cip1/Sdi1 enhances intestinal stem cell survival following radiation injury.
    George RJ; Sturmoski MA; May R; Sureban SM; Dieckgraefe BK; Anant S; Houchen CW
    Am J Physiol Gastrointest Liver Physiol; 2009 Feb; 296(2):G245-54. PubMed ID: 19056768
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Translation regulatory factor RBM3 is a proto-oncogene that prevents mitotic catastrophe.
    Sureban SM; Ramalingam S; Natarajan G; May R; Subramaniam D; Bishnupuri KS; Morrison AR; Dieckgraefe BK; Brackett DJ; Postier RG; Houchen CW; Anant S
    Oncogene; 2008 Jul; 27(33):4544-56. PubMed ID: 18427544
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Msi1 promotes tumor growth and cell proliferation by targeting cell cycle checkpoint proteins p21, p27 and p53 in cervical carcinomas.
    Liu X; Yang WT; Zheng PS
    Oncotarget; 2014 Nov; 5(21):10870-85. PubMed ID: 25362645
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SLC25A22 Promotes Proliferation and Survival of Colorectal Cancer Cells With KRAS Mutations and Xenograft Tumor Progression in Mice via Intracellular Synthesis of Aspartate.
    Wong CC; Qian Y; Li X; Xu J; Kang W; Tong JH; To KF; Jin Y; Li W; Chen H; Go MY; Wu JL; Cheng KW; Ng SS; Sung JJ; Cai Z; Yu J
    Gastroenterology; 2016 Nov; 151(5):945-960.e6. PubMed ID: 27451147
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic targeting of neuropilin-2 on colorectal carcinoma cells implanted in the murine liver.
    Gray MJ; Van Buren G; Dallas NA; Xia L; Wang X; Yang AD; Somcio RJ; Lin YG; Lim S; Fan F; Mangala LS; Arumugam T; Logsdon CD; Lopez-Berestein G; Sood AK; Ellis LM
    J Natl Cancer Inst; 2008 Jan; 100(2):109-20. PubMed ID: 18182619
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.